Sinofn Health
Sinofn Health
As the European Union intensifies its regulatory framework for Foods for Special Medical Purposes (FSMP) under Regulation (EU) No 609/2013, the Austrian market demands a higher standard of compliance, traceability, and clinical efficacy. Austria’s aging demographic, particularly in regions like Vienna and Salzburg, has spurred an exponential rise in the demand for specialized clinical nutrition—specifically for dysphagia, oncology support, and metabolic disorders like PKU.
Local Application Scenarios: In Austrian hospital settings and geriatric care facilities, there is a shifting trend towards "Medical Functional Foods." Our partnership with European experts ensures that the products we manufacture align with the Österreichische Agentur für Gesundheit und Ernährungssicherheit (AGES) standards, providing a secure, compliant supply chain for Austrian health distributors.
SINOFN leverages a unique dual-engine model. While manufacturing efficiency is driven by our cutting-edge Chinese facilities (backed by the Chinese Academy of Sciences), our R&D roadmap is influenced by Dutch and European regulatory specialists. This synergy allows us to offer:
Facility Size
Annual Capacity
Trademarks
We work closely with EU-based regulatory experts. Our production processes are FSSC 22000 and ISO 22000 certified, ensuring that every product exported meets the specific requirements of the Austrian Agency for Health and Food Safety (AGES).
Yes. Unlike mass-production factories, we offer flexible pilot-run solutions, allowing startups and clinics to test market viability before scaling up to full production.
By utilizing our vertically integrated system—from raw material extraction to final packaging—we mitigate external disruptions and maintain consistent quality and cost-efficiency.
